Breast Cancer Trial, By Invitation NCT06405269 Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, By Invitation

NCT06405269
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People with a good general health and activity level, scored as 0 or 1 on a standard medical performance scale (called the ECOG scale)
  • People with breast cancer that can be removed with surgery
  • People who, after surgery, have no signs of cancer that has spread to other parts of the body on imaging scans
  • People who are being considered for chemotherapy or other cancer treatment before or after surgery
  • People who have not previously taken cholesterol-lowering tablets and whose LDL ("bad") cholesterol level is within the normal range (below 3.4 mmol/L)
  • People who do not have a fatty liver, as confirmed by an ultrasound or CT scan of the liver
  • People whose major organs (such as the heart, kidneys, and liver) are functioning normally

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have been diagnosed with high cholesterol (hyperlipidaemia), coronary heart disease, or fatty liver disease, or who are currently taking or have previously taken cholesterol-lowering medication
  • People who are currently enrolled in another clinical study, or who stopped taking medications from another study less than 4 weeks ago
  • People who have serious problems with how one or more of their vital organs are working
  • People who have or have had another type of cancer, unless it was a skin cancer (non-melanoma) that was fully treated, cervical cancer in situ, or another cancer that was fully cured at least 5 years ago
  • People who have an active acute or chronic infectious disease
  • People who have a history of epilepsy, central nervous system disease, or a mental health condition that has not been well controlled

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 17 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Registry
ClinicalTrials.gov
Start date
6 May 2024
Est. completion
1 May 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Proportion of patients who developed LDL-C abnormalities in 3 groups

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 17 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov